Why DNA Tumour Sequencing is Necessary for Rare Cancers
Advancements in DNA sequencing continue to bring hope to patients with rare forms of cancer. The European Society for Medical Oncology (ESMO) explains how tumour sequencing allows specialists to determine which existing targeted therapies might work for rare cancers:
http://www.esmo.org/Press-Office/Press-Releases/DNA-Sequencing-Could-Open-Up-New-Drug-Indications-Patients-With-Rare-Cancers
And you don’t need to live in Europe to benefit from these leading edge genetic tests! CTOAM offers access to the most comprehensive genetic panels available – for a fraction of what it costs in the United States and overseas in EU.
Learn more about DNA tumour sequencing here:
https://www.ctoam.com/services/testing/genetic-testing/how-it-works/genetic-panels/
And other types of advanced diagnostics and genetic testing:
https://www.ctoam.com/services/testing/
Contact us to discover how you can access these life-saving tests that will identify the specific genetic mutations driving your unique form of cancer.
Get your FREE consultation today!
Phone: +1 (778) 999-5463
Email: [email protected]
Precision Oncology: The future of cancer treatment, now.
